Table 4.

Comparison of outcomes after Allogeneic HCT for pPCL between 2000 and 2006 (vs. MM patients during the same time period).

Outcomes	PPCL N-36	MM N-580	P-value
Non-relapse mortality
@ 1 year	27 (13-43)	24 (21-28)	0.773*
@ 3 years	44 (27-62)	29 (25-33)	0.094*
@ 5 years	52 (35-70)	29 (26-34)	0.015*
Relapse/Progression
@ 1 year	24 (11-40)	33 (29-36)	0.291*
@ 3 years	48 (30-65)	47 (43-52)	0.948*
@ 5 years	48 (30-65)	55 (50-61)	0.413*
Progression free survival
@ 1 year	49 (32-66)	43 (39-47)	0.512*
@ 3 years	8 (1-22)	24 (20-28)	0.006*
@ 5 years	8 (1-22)	15 (11-20)	<0.001*
Overall survival
@ 1 year	59 (42-75)	60 (56-64)	0.922*
@ 3 years	39 (23-56)	39 (35-44)	0.988*
@ 5 years	20 (1-53)	29 (24-34)	0.517*

^*Pointwise